viernes, 24 de febrero de 2017

ISRCTN - ISRCTN97125464: The SCOPE 2 Trial: Study of chemoradiotherapy in oesophageal cancer including PET response and dose escalation

ISRCTN - ISRCTN97125464: The SCOPE 2 Trial: Study of chemoradiotherapy in oesophageal cancer including PET response and dose escalation

BioMed Central – The Open Access Publisher



0

The SCOPE 2 Trial: Study of chemoradiotherapy in oesophageal cancer including PET response and dose escalation

No hay comentarios:

Publicar un comentario